Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Abiomed, Inc.    ABMD

ABIOMED, INC.

(ABMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société ABIOMED, INC.
01/14ABIOMED : Third Quarter Fiscal 2021 Earnings and Conference Call Notification
BU
01/07ABIOMED : Continues to Strengthen its Intellectual Property, Now Holds More Than..
BU
2020ABIOMED : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
2020ABIOMED : First Patients, Including a COVID-19 Patient, Treated with Abiomed's I..
AQ
2020ABIOMED : First Patients, Including a COVID-19 Patient, Treated with Abiomed's I..
BU
2020ABIOMED : Two Milestones Achieved Toward Small Bore Access with Impella
AQ
2020ABIOMED : Two Milestones Achieved Toward Small Bore Access with Impella
BU
2020ABIOMED : to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthc..
AQ
2020ABIOMED : to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthc..
BU
2020ABIOMED : to Hold Fireside Chat at the Stephens Annual Investment Conference 202..
BU
2020ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
2020ABIOMED : First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Hear..
AQ
2020ABIOMED : First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Hear..
BU
2020ABIOMED : Announces Q2 FY 2021 Revenue of $210 Million, Up 27% over Q1 FY 2021 a..
AQ
2020ABIOMED : First Patients Treated with the World's Smallest Heart Pump, the 9Fr I..
AQ
2020ABIOMED INC : Results of Operations and Financial Condition, Financial Statement..
AQ
2020ABIOMED : Fiscal 2Q Earnings Snapshot
AQ
2020ABIOMED : Announces Q2 FY 2021 Revenue of $210 Million, Up 27% Over Q1 FY 2021 a..
BU
2020ABIOMED : First Patients Treated with the World's Smallest Heart Pump, the 9Fr I..
BU
2020ABIOMED : FDA Grants 510(k) Clearance for Abiomed's Innovative Cardiopulmonary S..
AQ
2020ABIOMED : FDA Grants 510(k) Clearance for Abiomed's Innovative Cardiopulmonary S..
BU
2020ABIOMED : Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Car..
AQ
2020ABIOMED : Largest Study of Hemodynamically Supported High-Risk PCI Patients Find..
AQ
2020ABIOMED : to Host a Virtual Meeting to Discuss New Clinical Data Presented at TC..
AQ
2020ABIOMED : Studies Presented at TCT Connect Associate Higher Survival With Early ..
BU
2020ABIOMED : Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Car..
BU
2020ABIOMED : to Host a Virtual Meeting to Discuss New Clinical Data Presented at TC..
BU
2020ABIOMED : Largest Study of Hemodynamically Supported High-Risk PCI Patients Find..
BU
2020ABIOMED : Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves..
BU
2020ABIOMED : Second Quarter Fiscal 2021 Earnings and Conference Call Notification
AQ
2020ABIOMED : TCT Connect to Highlight How Impella Enables Improved Outcomes for Hig..
AQ
2020ABIOMED : Second Quarter Fiscal 2021 Earnings and Conference Call Notification
BU
2020ABIOMED : TCT Connect to Highlight How Impella Enables Improved Outcomes for Hig..
BU
2020ABIOMED : to Hold Fireside Chat at the Raymond James North American Equities Con..
AQ
2020ABIOMED : to Hold Fireside Chat at the Raymond James North American Equities Con..
BU
2020ABIOMED : to Hold Fireside Chat at the 18th Annual Morgan Stanley Global Healthc..
AQ
2020ABIOMED : to Hold Fireside Chat at the 18th Annual Morgan Stanley Global Healthc..
BU
2020ABIOMED INC : Other Events (form 8-K)
AQ
2020ABIOMED INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
2020ABIOMED INC : Results of Operations and Financial Condition, Financial Statement..
AQ
2020ABIOMED : Fiscal 1Q Earnings Snapshot
AQ
2020ABIOMED : Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin
BU
2020ABIOMED : FDA grants emergency use for heart pump in COVID-19 cases
AQ
2020ABIOMED : FDA Issues Emergency Use Authorization for Impella Heart Pumps to Prov..
BU
2020ABIOMED : Large Multi-Center Study in Japan Finds High Survival Rates with Use o..
AQ
2020ABIOMED : Large Multi-Center Study in Japan Finds High Survival Rates with Use o..
BU
2020ABIOMED : First Quarter Fiscal 2021 Earnings and Conference Call Notification
BU
2020ABIOMED : FDA Approves Data Streaming from the Impella Console, Setting the Stag..
BU
2020ABIOMED : Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Oth..
AQ
2020ABIOMED : Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Oth..
BU
2020ABIOMED : Appoints New Chief Medical Officer Charles Simonton, M.D
AQ
2020ABIOMED : Launches Virtual Physician Education Program, CAMP PCI, to Improve Hig..
BU
2020ABIOMED : Appoints New Chief Medical Officer Charles Simonton, M.D.
BU
2020ABIOMED : FDA Approves Abiomed's First-in-Human Trial of Impella ECP, World's Sm..
AQ
2020ABIOMED : FDA Approves Abiomed's First-in-Human Trial of Impella ECP, World's Sm..
BU
2020ABIOMED : to Hold Fireside Chat at the William Blair 40th Annual Growth Stock Co..
BU
2020ABIOMED : FDA Issues Emergency Use Authorization for Impella RP as Therapy for C..
AQ
2020ABIOMED : FDA Issues Emergency Use Authorization for Impella RP as Therapy for C..
BU
2020ABIOMED : to Hold Fireside Chat at Jefferies Virtual Healthcare Conference
BU
2020ABIOMED : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
2020ABIOMED : to Host Virtual Clinical Data and Innovation Day
BU
2020ABIOMED : PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Asso..
BU
2020ABIOMED INC : Other Events (form 8-K)
AQ
2020ABIOMED INC : Results of Operations and Financial Condition, Change in Directors..
AQ
2020ABIOMED : Fiscal 4Q Earnings Snapshot
AQ
2020ABIOMED : Announces Q4 FY 2020 Revenue of $207 Million and 28.1% Operating Margi..
BU
2020ABIOMED : Expands Product Portfolio with Acquisition of Cardiopulmonary Support ..
AQ
2020ABIOMED : Expands Product Portfolio with Acquisition of Cardiopulmonary Support ..
BU
2020ABIOMED : Fourth Quarter Fiscal 2020 Earnings and Conference Call Notification
AQ
2020ABIOMED : Fourth Quarter Fiscal 2020 Earnings and Conference Call Notification
BU
2020ABIOMED : Response to the COVID-19 Pandemic
AQ
2020ABIOMED : 's Response to the COVID-19 Pandemic
BU
2020ABIOMED : Study of 21,848 High-Risk PCI Patients Demonstrates Lower Risk of Deat..
BU
2020ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
1  2  3  4  5  6  7Next
Upcoming event on ABIOMED, INC.